KNSA: Kiniksa Pharmaceuticals Ltd - Class A
今日KNSA汇率已更改1.55%。当日,交易品种以低点62.48和高点63.87进行交易。
关注Kiniksa Pharmaceuticals Ltd - Class A动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
KNSA新闻
- Profitable Biotechs Strut Their Stuff As Stock Market Stumbles
- Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout
- UnitedHealth Tops Q2 Earnings on Cost Control, Raises '26 Outlook
- ATAI Stock Soars on Reports of Potential Acquisition by Eli Lilly
- AZN Inks Deal With Dizal to In-License Rights to Lung Cancer Drug
- Kiniksa Pharmaceuticals - Leader In Pericarditis Merits Hold After Recent Gains (KNSA)
- 4 Top-Ranked Stocks With Solid Net Profit Margins to Boost Your Gains
- Axsome Begins Phase III Study on Solriamfetol for ADHD in Children
- AGIO's Filing for Mitapivat in SCD Gets FDA's Priority Tag, Stock Up
- Illumina, Inc. (ILMN) Hit a 52 Week High, Can the Run Continue?
- Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why
- What Makes Kiniksa Pharmaceuticals International, plc (KNSA) a Strong Momentum Stock: Buy Now?
- EVMN Stock Tanks as Phase IIb Urticaria Study Misses Primary Goal
- Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains?
- J&J Wins CHMP Nod for Expanded Use of Multiple Myeloma Drug Tecvayli
- ABBV Gets CHMP Nod for Rinvoq in Two Different Autoimmune Diseases
- Grab These 4 Stocks With Solid Net Profit Margins to Maximize Returns
- Here's Why You Should Add Kiniksa Stock to Your Portfolio Now
- AbbVie Gets EU Nod for Skyrizi in Pediatric Plaque Psoriasis
- Biotech Kiniksa Pushes Toward A Buy Zone With Blockbuster Drug Sales In View
- Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going
- New Strong Buy Stocks for June 18th
- Aerospace Hotshot Woodward Leads 14 Newcomers Onto Best Stock Lists
- Kiniksa Pharmaceuticals International, plc (KNSA) Upgraded to Strong Buy: Here's What You Should Know
常见问题解答
KNSA股票今天的价格是多少?
Kiniksa Pharmaceuticals Ltd - Class A股票今天的定价为63.55。它在62.48 - 63.87范围内交易,昨天的收盘价为62.58,交易量达到888。KNSA的实时价格图表显示了这些更新。
Kiniksa Pharmaceuticals Ltd - Class A股票是否支付股息?
Kiniksa Pharmaceuticals Ltd - Class A目前的价值为63.55。股息政策取决于公司,而投资者也会关注60.30%和USD。实时查看图表以跟踪KNSA走势。
如何购买KNSA股票?
您可以以63.55的当前价格购买Kiniksa Pharmaceuticals Ltd - Class A股票。订单通常设置在63.55或63.85附近,而888和1.71%显示市场活动。立即关注KNSA的实时图表更新。
如何投资KNSA股票?
投资Kiniksa Pharmaceuticals Ltd - Class A需要考虑年度范围35.20 - 67.53和当前价格63.55。许多人在以63.55或63.85下订单之前,会比较-0.14%和。实时查看KNSA价格图表,了解每日变化。
Kiniksa Pharmaceuticals Ltd - Class A股票的最高价格是多少?
在过去一年中,Kiniksa Pharmaceuticals Ltd - Class A的最高价格是67.53。在35.20 - 67.53内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Kiniksa Pharmaceuticals Ltd - Class A的绩效。
Kiniksa Pharmaceuticals Ltd - Class A股票的最低价格是多少?
Kiniksa Pharmaceuticals Ltd - Class A(KNSA)的最低价格为35.20。将其与当前的63.55和35.20 - 67.53进行比较,可以发现潜在的长期切入点。观看KNSA在图表上的实时走势以获取更多详细信息。
KNSA股票是什么时候拆分的?
Kiniksa Pharmaceuticals Ltd - Class A历史上曾经历过股票拆分。这些变化在公司行动后的、62.58和60.30%中可见。
- 前一天收盘价
- 62.58
- 开盘价
- 62.48
- 卖价
- 63.55
- 买价
- 63.85
- 最低价
- 62.48
- 最高价
- 63.87
- 交易量
- 888
- 日变化
- 1.55%
- 月变化
- -0.14%
- 6个月变化
- 45.59%
- 年变化
- 60.30%
- 实际值
- 预测值
- 1.978 M
- 前值
- -1.692 M
- 实际值
- 预测值
- 0.992 M
- 前值
- 0.430 M
- 实际值
- 预测值
- 前值
- 4.927%